GRIA2 and Huntington disease: We performed quantitative immunohistochemistry to examine whether AMPA receptor subunit expression is altered in PD or HD in the human hippocampus and striatum by examining the expression of the GluA2 subunit common to both these receptor subtypes that could therefore reflect changes in either subtype of receptor (Figure 3).